why choose us

First received: September 21, 2022

Clinical Trial: Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Shingles

Study Type: INTERVENTIONAL


Official Title: Phase II, Non-randomized, Open-label Study to Assess the Immunogenicity and Clinical Efficacy of the Recombinant Zoster Vaccine for Recipients of an Allogeneic Hematopoietic Stem Cell Transplant

Brief Summary: This is a phase II study that will examine the immunogenicity of the Shingrix vaccine in patients following an allogeneic stem cell transplant.

Read more